|
Originally published In Press as doi:10.1074/jbc.M505720200 on October 11, 2005
J. Biol. Chem., Vol. 280, Issue 51, 42274-42282, December 23, 2005
Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1·FGFR2c·Heparin Ternary Complexes*
Christopher J. Robinson 1,
Nicholas J. Harmer ,
Sarah J. Goodger ,
Tom L. Blundell , and
John T. Gallagher
From the
Cancer Research UK and Department of Medical Oncology, University of Manchester, Christie Hospital National Health Service Trust, Wilmslow Road, Manchester M20 4BX and the Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom
The related glycosaminoglycans heparin and heparan sulfate are essential for the activity of the fibroblast growth factor (FGF) family as they form an integral part of the signaling complex at the cell surface. Using size-exclusion chromatography we have studied the capacities of a variety of heparin oligosaccharides to bind FGF1 and FGFR2c both separately and together in ternary complexes. In the absence of heparin, FGF1 had no detectable affinity for FGFR2c. However, 2:2:1 complexes formed spontaneously in solution between FGF1, FGFR2c, and heparin octasaccharide (dp8). The dp8 sample was the shortest chain length that bound FGFR2c, that dimerized FGF1, and that promoted a strong mitogenic response to FGF1 through FGFR2c. Heparin hexasaccharide and various selectively desulfated heparin dp12s failed to bind FGFR2c and could only interact with FGF1 monomerically. These saccharides formed 1:1:1 complexes with FGF1 and FGFR2c, which had no tendency to self-associate, suggesting that binding of two FGF1 molecules to the same saccharide chain is a prerequisite for subsequent FGFR2c dimerization. We found that FGF1 dimerization upon heparin was favored over monomeric interactions even when a large excess of saccharide was present. A cooperative mechanism of FGF1 dimerization could explain how 2:2:1 signaling complexes form at the cell surface, an environment rich in heparan sulfate.
Received for publication, May 25, 2005
, and in revised form, September 28, 2005.
* This work was supported by funding from Cancer Research UK. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed. Tel.: 0161-446-3819; Fax: 0161-446-3269; E-mail: Christopher.Robinson{at}manchester.ac.uk.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Ashikari-Hada, H. Habuchi, N. Sugaya, T. Kobayashi, and K. Kimata
Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate
Glycobiology,
June 1, 2009;
19(6):
644 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Goodger, C. J. Robinson, K. J. Murphy, N. Gasiunas, N. J. Harmer, T. L. Blundell, D. A. Pye, and J. T. Gallagher
Evidence That Heparin Saccharides Promote FGF2 Mitogenesis through Two Distinct Mechanisms
J. Biol. Chem.,
May 9, 2008;
283(19):
13001 - 13008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sugaya, H. Habuchi, N. Nagai, S. Ashikari-Hada, and K. Kimata
6-O-Sulfation of Heparan Sulfate Differentially Regulates Various Fibroblast Growth Factor-dependent Signalings in Culture
J. Biol. Chem.,
April 18, 2008;
283(16):
10366 - 10376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Catlow, J. A. Deakin, Z. Wei, M. Delehedde, D. G. Fernig, E. Gherardi, J. T. Gallagher, M. S. G. Pavao, and M. Lyon
Interactions of Hepatocyte Growth Factor/Scatter Factor with Various Glycosaminoglycans Reveal an Important Interplay between the Presence of Iduronate and Sulfate Density
J. Biol. Chem.,
February 29, 2008;
283(9):
5235 - 5248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tan, M. Duquette, J.-h. Liu, K. Shanmugasundaram, A. Joachimiak, J. T. Gallagher, A. C. Rigby, J.-h. Wang, and J. Lawler
Heparin-induced cis- and trans-Dimerization Modes of the Thrombospondin-1 N-terminal Domain
J. Biol. Chem.,
February 15, 2008;
283(7):
3932 - 3941.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-A. Hussain, M. Piper, N. Fukuhara, L. Strochlic, G. Cho, J. A. Howitt, Y. Ahmed, A. K. Powell, J. E. Turnbull, C. E. Holt, et al.
A Molecular Mechanism for the Heparan Sulfate Dependence of Slit-Robo Signaling
J. Biol. Chem.,
December 22, 2006;
281(51):
39693 - 39698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. McDowell, B. A. Frazier, D. R. Studelska, K. Giljum, J. Chen, J. Liu, K. Yu, D. M. Ornitz, and L. Zhang
Inhibition or Activation of Apert Syndrome FGFR2 (S252W) Signaling by Specific Glycosaminoglycans
J. Biol. Chem.,
March 17, 2006;
281(11):
6924 - 6930.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|